[HTML][HTML] Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
AJ Mackay, K Kostikas, N Roche, SM Frent… - Respiratory …, 2020 - Springer
Background COPD is a heterogeneous disease and patients may respond differently to
therapies depending on baseline symptom burden. Methods This post-hoc analysis from the …
therapies depending on baseline symptom burden. Methods This post-hoc analysis from the …
Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study.
AJ Mackay, K Kostikas, N Roche, SM Frent… - Respiratory …, 2020 - europepmc.org
Background COPD is a heterogeneous disease and patients may respond differently to
therapies depending on baseline symptom burden. Methods This post-hoc analysis from the …
therapies depending on baseline symptom burden. Methods This post-hoc analysis from the …
[PDF][PDF] Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
AJ Mackay, K Kostikas, N Roche, SM Frent, P Olsson… - 2020 - scholar.archive.org
Background: COPD is a heterogeneous disease and patients may respond differently to
therapies depending on baseline symptom burden. Methods: This post-hoc analysis from …
therapies depending on baseline symptom burden. Methods: This post-hoc analysis from …
[HTML][HTML] Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
AJ Mackay, K Kostikas, N Roche… - Respiratory …, 2020 - respiratory-research.biomedcentral …
COPD is a heterogeneous disease and patients may respond differently to therapies
depending on baseline symptom burden. This post-hoc analysis from the 52-week FLAME …
depending on baseline symptom burden. This post-hoc analysis from the 52-week FLAME …
Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
AJ Mackay, K Kostikas, N Roche… - Respiratory …, 2020 - pubmed.ncbi.nlm.nih.gov
Background COPD is a heterogeneous disease and patients may respond differently to
therapies depending on baseline symptom burden. Methods This post-hoc analysis from the …
therapies depending on baseline symptom burden. Methods This post-hoc analysis from the …
[HTML][HTML] Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
AJ Mackay, K Kostikas, N Roche, SM Frent… - Respiratory …, 2020 - ncbi.nlm.nih.gov
Background COPD is a heterogeneous disease and patients may respond differently to
therapies depending on baseline symptom burden. Methods This post-hoc analysis from the …
therapies depending on baseline symptom burden. Methods This post-hoc analysis from the …
[引用][C] Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
AJ Mackay, K Kostikas, N Roche, SM Frent… - Respiratory Research …, 2020 - jglobal.jst.go.jp
Am J Respir Crit Care Med; Global strategy for the diagnosis, management, and prevention
of chronic obstructive lung disease 2017 report. GOLD executive summary; CF Vogelmeier …
of chronic obstructive lung disease 2017 report. GOLD executive summary; CF Vogelmeier …
[PDF][PDF] Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
AJ Mackay, K Kostikas, N Roche, SM Frent, P Olsson… - 2020 - academia.edu
Background: COPD is a heterogeneous disease and patients may respond differently to
therapies depending on baseline symptom burden. Methods: This post-hoc analysis from …
therapies depending on baseline symptom burden. Methods: This post-hoc analysis from …
Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
AJ Mackay, K Kostikas, N Roche, SM Frent… - Respiratory …, 2020 - search.proquest.com
Background COPD is a heterogeneous disease and patients may respond differently to
therapies depending on baseline symptom burden. Methods This post-hoc analysis from the …
therapies depending on baseline symptom burden. Methods This post-hoc analysis from the …
[PDF][PDF] Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
AJ Mackay, K Kostikas, N Roche, SM Frent, P Olsson… - 2020 - academia.edu
Background: COPD is a heterogeneous disease and patients may respond differently to
therapies depending on baseline symptom burden. Methods: This post-hoc analysis from …
therapies depending on baseline symptom burden. Methods: This post-hoc analysis from …